Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 2, 2009, Pages

  Brands, Michael W ^a   Bell, Tracy D ^a   Rodriquez, Nancy A ^a   Polavarapu, Praveen ^a   Panteleyev, Dmitriy ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Blood pressure; Metabolic syndrome; Sodium excretion

Indexed keywords

GLUCOSE; INSULIN; RENIN; PROSTAGLANDIN; SODIUM; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; KIDNEY BLOOD FLOW; KIDNEY MASS; KIDNEY TUBULE ABSORPTION; MACULA DENSA; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PERIPHERAL EDEMA; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SALT INTAKE; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM RETENTION; SODIUM URINE LEVEL; STATISTICAL SIGNIFICANCE; VASODILATATION; ANIMAL; BLOOD; BLOOD FLOW; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; HYPERINSULINISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CIRCULATION; KIDNEY TUBULE; METABOLISM; NEPHRECTOMY; PATHOPHYSIOLOGY; TIME; URINE; VASCULAR RESISTANCE; VASCULARIZATION;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOGS; GLOMERULAR FILTRATION RATE; GLUCOSE; HYPERGLYCEMIA; HYPERINSULINISM; HYPERTENSION; INFUSIONS, INTRAVENOUS; INSULIN; KIDNEY TUBULES; MALE; NATRIURESIS; NEPHRECTOMY; PROSTAGLANDINS; REGIONAL BLOOD FLOW; RENAL CIRCULATION; RENIN; SODIUM; SODIUM CHLORIDE, DIETARY; THROMBOXANES; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION;

EID: 61949446299     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90528.2008     Document Type: Article

References (42)

1. Bell TD, DiBona GF, Wang Y, Brands MW. Mechanisms for renal blood flow control early in diabetes as revealed by chronic flow measurement and transfer function analysis. J Am Soc Nephrol 17: 2184-2192, 2006. (Pubitemid 44141908)
2. Brands MW, Fitzgerald SM. Chronic intravenous glucose infusion causes moderate hypertension in rats. Am J Hypertens 13: 99-102, 2000.
3. Brands MW, Hailman AE, Fitzgerald SM. Long-term glucose infusion increases arterial pressure in dogs with cyclooxygenase-2 inhibition. Hypertension 37: 733-738, 2001.
4. Brands MW, Harrison DL, Keen HL, Garnder A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension 29: 1014-1019, 1997.
5. Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 271: R276-R281, 1996. (Pubitemid 26307130)
6. Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs. Am J Hypertens 4: 164-168, 1991.
7. Claxton CR, Cameron JA, Fitzgerald SM, Brands MW. Inhibition of nitric oxide synthesis potentiates hypertension during chronic glucose infusion in rats. Hypertension 35: 451-456, 2000.
8. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 293: H2009-H2023, 2007. (Pubitemid 47605846)
9. DeFronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia 21: 165-171, 1981.
10. de Paula RB, da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 43: 41-47, 2004.
11. Friedberg CE, van Buren M, Bijlsma JA, Koomans HA. Insulin increases sodium reabsorption in diluting segment in humans: evidence for indirect mediation through hypokalemia. Kidney Int 40: 251-256, 1991.
12. Galipeau D, Arikawa E, Sekirov I, McNeill JH. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension 38: 872-876, 2001. (Pubitemid 34258685)
13. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 22: 292-299, 1993.
14. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines? Hypertension 15: 519-527, 1990.
15. Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 260: F663-F669, 1991.
16. Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart GA, Hildebrandt DA. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs. Hypertension 25: 994-1002, 1995.
17. Hall JE, Coleman TG, Mizelle HL, Smith MJJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol Renal Fluid Electrolyte Physiol 258: F722-F731, 1990.
18. Hall JE, Guyton AC, Farr BM. A single-injection method for measuring glomerular filtration rate. Am J Physiol Renal Fluid Electrolyte Physiol 232: F72-F76, 1977.
19. Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Pressure natriuresis and angiotensin II in reduced kidney mass, salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 262: R61-R71, 1992.
20. Hsieh PS. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats. J Hypertens 23: 2209-2217, 2005.
21. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25: 893-897, 1995.
22. Katakam PVG, Ujhelyi MR, Hoenig ME, Miller AW. Endothelial dysfunction precedes hypertension in diet-induced. Am J Physiol Regul Integr Comp Physiol 275: R788-R792, 1998.
23. Katovich MJ, Iyer SN. Effect of chronic losartan potassium treatment on fructose-induced hypertension. Life Sci 55: 134-144, 1994.
24. Keen HL, Brands MW, Smith MJJ, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats. Hypertension 31: 637-642, 1998.
25. Keen HL, Brands MW, Smith MJJ, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats. Am J Hypertens 10: 1125-1131, 1997.
26. Kirchner KA. Insulin increases loop segment chloride reabsorption in the euglycemic rat. Am J Physiol Renal Fluid Electrolyte Physiol 255: F1206-F1213, 1988.
27. Landsberg L. Insulin sensitivity in the pathogenesis of hypertension and hypertensive complications. Clin Exp Hypertens 18: 337-346, 1996. (Pubitemid 26148652)
28. Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 13: 365-373, 2006. (Pubitemid 44512240)
29. Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10: 1778-1785, 1999.
30. Nishimoto Y, Tomida T, Matsui H, Ito T, Okumura K. Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats. Hypertension 40: 190-194, 2002.
31. Osei SY, Price DA, Fisher ND, Porter L, Laffel LM, Hollenberg NK. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Hypertension 33: 559-564, 1999. (Pubitemid 29065720)
32. Pamies-Andreu E, Fiksen-Olsen M, Rizza R, Romero JC. High-fructose feeding elicits insulin resistance without hypertension in normal mongrel dogs. Am J Hypertens 8: 732-738, 1995.
33. Robles RG, Villa E, Santirso R, Martinez J, Ruilope LM, Cuesta C, Sancho JM. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am J Hypertens 6: 1009-1019, 1993. (Pubitemid 24037572)
34. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol 27: 44-54, 2007.
35. Sarafidis PA, Whaley-Connell A, Sowers JR, Bakris GL. Cardiometabolic syndrome and chronic kidney disease: what is the link? J Cardiometab Syndr 1: 58-65, 2006.
36. Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 43: 255-262, 2004. (Pubitemid 38174184)
37. Song J, Hu X, Shi M, Knepper MA, Ecelbarger CA. Effects of dietary fat, NaCl, and fructose on renal sodium and water transporter abundances and systemic blood pressure. Am J Physiol Renal Physiol 287: F1204-F1212, 2004. (Pubitemid 39507229)
38. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 286: H1597-H1602, 2004.
39. Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, D'Elia L, Russo O, Versiero M, Farinaro E, Cappuccio FP. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens 24: 1633-1639, 2006. (Pubitemid 44162466)
40. Tiwari S, Riazi S, Ecelbarger CA. Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes. Am J Physiol Renal Physiol 293: F974-F984, 2007. (Pubitemid 47583930)
41. Van der Schaaf MR, Koomans HA, Joles JA. Dietary sucrose does not increase twenty-four-hour ambulatory blood pressure in patients with either essential hypertension or polycystic kidney disease. J Hypertens 17: 453-454, 1999.
42. Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Am J Physiol Renal Fluid Electrolyte Physiol 252: F65-F71, 1987.